Showing results (151-160 of 1,359) with videos related to
Sort By:
Pageof 136
Haemostasis|January 1, 1980
Utilization of drugs active on the haemostatic system in intensive care units: a retrospective analysisM L Farina, A Levati, G TognoniHaemostasis|January 1, 1989
Bleeding and thrombosis in chronic myeloproliferative disorders: relation of platelet disorders to clinical aspects of the diseaseA Wehmeier, R E Scharf, S Fricke, et al.Haemostasis|January 1, 1991
Antiplatelet glycoprotein Ib monoclonal antibody (OP-F1) totally abolishes ristocetin-induced von Willebrand factor binding, but has minimal effect on the botrocetin-induced bindingK Nishio, Y Fujimura, S Nishida, et al.Haemostasis|January 1, 1989
Tanakan inhibits platelet-activating-factor-induced platelet aggregation in healthy male volunteersP Guinot, E Caffrey, R Lambe, et al.Haemostasis|January 1, 1989
Effect of antibiotics on laser-induced thrombus formation in rat mesenteric arteriolesW Weichert, H K BreddinHaemostasis|January 1, 1988
Evaluation of the biological effects of low-molecular-weight heparinsN Bender, C Seidl, W Weichert, et al.Haemostasis|January 1, 1988
Validity of the newly established low-molecular-weight heparin standard in cross-referencing low-molecular-weight heparinsJ Fareed, J M Walenga, A Racanelli, et al.Haemostasis|January 1, 1988
Effect of low-molecular-weight heparins on laser-induced thrombus formation in rat mesenteric vesselsW Weichert, H K BreddinHaemostasis|January 1, 1988
Experimental investigations on the thrombosis-preventing effect of low-molecular-weight heparinsG Harbauer, A AllendorfHaemostasis|January 1, 1988
Primary and secondary long-term prophylaxis of thromboembolism in outpatients with the low-molecular-weight heparin Kabi 2165J Harenberg, G Leber, R Raedsch, et al.Pageof 136